Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("TANNER, C. M")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 80

  • Page / 4
Export

Selection :

  • and

Epidemiology of Parkinson's diseaseTANNER, C. M.Neurologic clinics. 1992, Vol 10, Num 2, pp 317-329, issn 0733-8619Article

Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortiumMCGUIRE, V; VAN DEN EEDEN, S. K; TOPOL, B et al.Journal of the neurological sciences. 2011, Vol 307, Num 1-2, pp 22-29, issn 0022-510X, 8 p.Article

Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson diseasePOPAT, R. A; VAN DEN EEDEN, S. K; TANNER, C. M et al.Neurology. 2005, Vol 65, Num 3, pp 383-390, issn 0028-3878, 8 p.Article

Midlife adiposity and the future risk of Parkinson's diseaseABBOTT, R. D; ROSS, G. W; WHITE, L. R et al.Neurology. 2002, Vol 59, Num 7, pp 1051-1057, issn 0028-3878Article

Absence of mutations in the coding region of the α-synuclein gene in pathologically proven Parkinson's diseaseCHAN, P; JIANG, X; FORNO, L. S et al.Neurology. 1998, Vol 50, Num 4, pp 1136-1137, issn 0028-3878Article

CYP2D6 allelic frequencies in young-onset Parkinson's diseaseSANDY, M. S; ARMSTRONG, M; TANNER, C. M et al.Neurology. 1996, Vol 47, Num 1, pp 225-230, issn 0028-3878Article

Double-blind, placebo-controlled, crossover study of duodenal infusion of levodopa/carbidopa in Parkinson's disease patients with on-off fluctuationsKURTH, M. C; TETRUD, J. W; TANNER, C. M et al.Neurology. 1993, Vol 43, Num 9, pp 1698-1703, issn 0028-3878Article

Dopaminergic agonists in the treatment of Parkinson's disease. DiscussionGOETZ, C. G; KLAWANS, H. L; OLANOW, C. W et al.Neurology. 1990, Vol 40, Num 10, pp 50-57, issn 0028-3878, 8 p., Suppl. 3Article

The genetics of Parkinson's disease : a reconsideration. DiscussionGOLBE, L. I; OLANOW, C. W; TANNER, C. M et al.Neurology. 1990, Vol 40, Num 10, pp 7-16, issn 0028-3878, 10 p., Suppl. 3Article

Dietary intake in adults at risk for Huntington disease: Analysis of PHAROS Research ParticipantsMARDER, K; ZHAO, H; EBERLY, S et al.Neurology. 2009, Vol 73, Num 5, pp 385-392, issn 0028-3878, 8 p.Article

Optimizing the ongoing search for new treatments for parkinson disease : Using futility designsTILLEY, B. C; PALESCH, Y. Y; KIEBURTZ, K et al.Neurology. 2006, Vol 66, Num 5, pp 628-633, issn 0028-3878, 6 p.Article

Survival in Parkinson disease: Thirteen-year follow-up of the DATATOP cohortMARRAS, C; MCDERMOTT, M. P; ROCHON, P. A et al.Neurology. 2005, Vol 64, Num 1, pp 87-93, issn 0028-3878, 7 p.Article

Parkinson disease in twins: An etiologic studyTANNER, C. M; OTTMAN, R; GOLDMAN, S. M et al.JAMA, the journal of the American Medical Association. 1999, Vol 281, Num 4, pp 341-346, issn 0098-7484Article

Agonist substitution in advanced Parkinson's diseaseGOETZ, C. G; SHANNON, K. M; TANNER, C. M et al.Neurology. 1989, Vol 39, Num 8, pp 1121-1122, issn 0028-3878Article

Concurrent treatment with benztropine and haloperidol attenuates development of behavioral hypersensitivity but not dopamine receptor proliferationCARVEY, P. M; HITRI, A; GOETZ, C. G et al.Life sciences (1973). 1988, Vol 42, Num 22, pp 2207-2215, issn 0024-3205Article

Neuroleptic malignant syndrome responsive to carbidopa/LEVODOPA: support for a dopaminergic pathogenesisHARRIS, M; NORA, L; TANNER, C. M et al.Clinical neuropharmacology. 1987, Vol 10, Num 2, pp 186-189, issn 0362-5664Article

Progression of Parkinson's disease without levodopaGOETZ, C. G; TANNER, C. M; SHANNON, K. M et al.Neurology. 1987, Vol 37, Num 4, pp 695-698, issn 0028-3878Article

Myoclonus and ParkinsonismKLAWANS, H. L; TANNER, C. M; MCDERMOTT, J et al.Clinical neuropharmacology. 1986, Vol 9, Num 2, pp 202-205, issn 0362-5664Article

Pergolide in Parkinson's diseaseGOETZ, C. G; TANNER, C. M; GLANTZ, R et al.Archives of neurology (Chicago). 1983, Vol 40, Num 13, pp 785-787, issn 0003-9942Article

Projected number of people with parkinson disease in the most populous nations, 2005 through 2030DORSEY, E. R; CONSTANTINESCU, R; TANNER, C. M et al.Neurology. 2007, Vol 68, Num 5, pp 384-386, issn 0028-3878, 3 p.Article

Frequency of bowel movements and the future risk of Parkinson's diseaseABBOTT, R. D; PETROVITCH, H; WHITE, L. R et al.Neurology. 2001, Vol 57, Num 3, pp 456-462, issn 0028-3878Article

Essential tremor in twins: An assessment of genetic vs environmental determinants of etiologyTANNER, C. M; GOLDMAN, S. M; LYONS, K. E et al.Neurology. 2001, Vol 57, Num 8, pp 1389-1391, issn 0028-3878Article

False-positive findings on lumbar discography. Reliability of subjective concordance assessment during provocative disc injectionCARRAGEE, E. J; TANNER, C. M; YANG, B et al.Spine (Philadelphia, PA. 1976). 1999, Vol 24, Num 23, pp 2542-2547, issn 0362-2436Article

Epidemiology of Tourette syndromeTANNER, C. M; GOLDMAN, S. M.Neurologic clinics. 1997, Vol 15, Num 2, issn 0733-8619, xii, 395-402 [9 p.]Article

Epidemiology of Parkinson's diseaseTANNER, C. M; GOLDMAN, S. M.Neurologic clinics. 1996, Vol 14, Num 2, issn 0733-8619, viii, 317-335 [20 p.]Article

  • Page / 4